Press Room

There are 3 item(s) tagged with the keyword "Novo Nordisk".

1. JDRF Partner ViaCyte Announces Key Project Milestone

JDRF Partner ViaCyte Announces Key Project Milestone to Advance Innovative Encapsulated Cell Replacement Therapy Product for Type 1 Diabetes


2. Novo Nordisk Commits $5 Million Grant Supporting JDRF Outreach Initiative

To address the need for education on how patients with type 1 diabetes (T1D) can pursue physical activity safely, Novo Nordisk has committed to a three-year, $5 million grant in support of a new JDRF Outreach initiative titled “T1D Performance in Exercise and Knowledge ...


3. EFSD, JDRF and Novo Nordisk renew partnership for type 1 diabetes research in Europe

Stockholm, Sweden, Sept. 22, 2010 --- The European Foundation for the Study of Diabetes (EFSD), the Juvenile Diabetes Research Foundation (JDRF) and Novo Nordisk A/S announced today the renewal of their partnership to support type 1 diabetes research in Europe. The announcement was made at the European ...


Lets turn type one into type none